SJ Medical
SJ Medical
Renal Artery Denervation (RDN) has emerged as a revolutionary therapeutic approach for patients suffering from resistant hypertension—a condition where blood pressure remains uncontrolled despite the use of multiple medications. As a leading Renal Artery Denervation manufacturer, we have witnessed a seismic shift in how the global medical community perceives this interventional procedure. Historically, hypertension was managed strictly through pharmaceutical means; however, the advent of Radiofrequency (RF) and Ultrasound-based ablation technologies has opened new doors for long-term physiological control.
The global RDN market is projected to grow at a CAGR of over 15% through 2030. Key drivers include the rising prevalence of metabolic syndromes and the FDA's recent approvals of major RDN systems. Industrial manufacturing has shifted toward high-precision catheter systems that offer multi-electrode capabilities, ensuring more complete circumferential ablation of the sympathetic nerves surrounding the renal arteries.
Modern RDN technology is moving toward "Smart Ablation." This includes integrated real-time feedback loops that monitor temperature and impedance to prevent artery wall damage. Furthermore, there is a significant trend in downsizing the delivery systems to 4Fr or 5Fr profiles, allowing for safer access through the radial or femoral arteries with minimal patient recovery time.
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes. The company is supported by a highly experienced technical team, many of whom have been engaged in the medical device industry for decades.
As the global demand for cost-effective yet high-quality medical devices surges, China has become a central hub for interventional device manufacturing. For international procurement officers and hospital administrators, sourcing from a specialized factory like SJ Medical offers unique advantages:
We leverage China's mature industrial ecosystem for raw materials like Nitinol, Pebax, and medical-grade stainless steel. This allows us to maintain consistent production cycles and competitive pricing without compromising on clinical efficacy.
Our proximity to rapid prototyping centers and clinical research hospitals in Hangzhou enables us to iterate on catheter designs faster than many Western competitors. We can customize sheath lengths, tip flexibility, and electrode configurations to meet specific regional clinical needs.
Our facility is equipped with advanced production and inspection systems, including precision balloon forming equipment, laser welding, and comprehensive laboratory testing. We ensure every unit meets the highest biocompatibility and mechanical safety standards.
In Europe and North America, RDN is increasingly integrated into "Hypertension Centers of Excellence." In emerging markets across Asia and the Middle East, the focus is on providing reliable access to this technology in specialized cardiac catheterization labs. Our products, such as Renal Dilators and Ureteral Access Sheaths, provide the necessary clinical support to ensure successful RDN procedures by facilitating smooth arterial navigation and protection.
SJ Medical focuses on the development of vascular interventional devices designed for both coronary and peripheral procedures. Its product range integrates interventional access systems, diagnostic catheters, and therapeutic devices, forming a complete solution for minimally invasive vascular treatments. Each product is developed with an emphasis on precision, safety, and clinical performance.
The company’s products are widely applied in minimally invasive procedures involving both coronary and peripheral vascular systems. They play an important role in the diagnosis and treatment of vascular diseases, helping to improve procedural efficiency while enhancing patient safety and recovery.
SJ Medical strictly adheres to international quality standards. The company has obtained CE certification, ISO 13485 quality management system certification, and CFDA approval, along with free sale certificates, demonstrating its strong commitment to product quality and compliance.
SJ Medical has established long-term partnerships with clients across Europe, Asia, the Middle East, and Africa. Its products are currently distributed in countries such as Finland, Italy, Spain, France, the Netherlands, India, Indonesia, Turkey, and Egypt.
We provide more than just medical hardware; we provide a partnership. Our services cover the entire product lifecycle:
